Cargando…
Sodium Reduction, miRNA Profiling and CVD Risk in Untreated Hypertensives: a Randomized, Double-Blind, Placebo-Controlled Trial
Sodium reduction decreases blood pressure (BP) and cardiovascular mortality. However, the underlying molecular mechanisms are not well understood. We tested the hypothesis that reduction of sodium intake would change miRNA expression in hypertensive patients, and those changes would be associated wi...
Autores principales: | Chen, Li, He, Feng J., Dong, Yanbin, Huang, Ying, Harshfield, Gregory A., Zhu, Haidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109065/ https://www.ncbi.nlm.nih.gov/pubmed/30143705 http://dx.doi.org/10.1038/s41598-018-31139-5 |
Ejemplares similares
-
High sodium intake is associated with short leukocyte telomere length in overweight and obese adolescents
por: Zhu, Haidong, et al.
Publicado: (2015) -
Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation
por: Joksić, Gordana, et al.
Publicado: (2011) -
Sixteen-Week Vitamin D(3) Supplementation Increases Peripheral T Cells in Overweight Black Individuals: Post hoc Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial
por: Dong, Yutong, et al.
Publicado: (2022) -
Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial
por: Kasang, Christa, et al.
Publicado: (2016) -
A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males
por: Wang, Xiaoling, et al.
Publicado: (2013)